A lung cancer patient at Wythenshawe Hospital has taken part in a national project led by Manchester researchers, investigating changes in radiotherapy treatments during COVID-19.
A drug has shown potential to improve heart function in women diagnosed with preeclampsia during their pregnancy, research carried out at Saint Mary’s Hospital has found.
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan